Purified Vero Cell Rabies Vaccine (PVRV, Verorab® ): A Systematic Review of Intradermal Use Between 1985 and 2019

Tropical Medicine and Infectious Disease
Thomas MoulenatGuy Houillon

Abstract

The purified Vero cell rabies vaccine (PVRV; Verorab®, Sanofi Pasteur) has been used in rabies prevention since 1985. Evolving rabies vaccination trends, including shorter intradermal (ID) regimens with reduced volume, along with WHO recommendation for ID administration has driven recent ID PVRV regimen assessments. Thus, a consolidated review comparing immunogenicity of PVRV ID regimens during pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) is timely and beneficial in identifying gaps in current research. A search of seven databases for studies published from 1985 to November 2019 identified 35 studies. PrEP was assessed in 10 studies (n = 926) with 1-3-site, 1-3-visit regimens of up to 3-months duration. Seroconversion (rabies virus neutralizing antibodies [RVNA] ≥ 0.5 IU/mL) rates of 90-100% were reported within weeks, irrespective of regimen, with robust booster responses at 1 year (100% seroconversion rates by day 14 post-booster). However, data are lacking for the current WHO-recommended, 2-site, 1-week ID PrEP regimen. PEP was assessed in 25 studies (n = 2136) across regimens of 1-week to 90-day duration. All ID PEP regimens assessed induced ≥ 99% seroconversion rates (except in HIV participants) by d...Continue Reading

References

Oct 6, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C KositprapaC Supich
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T TantawichienV Sitprija
Oct 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T TantawichienV Sitprija
Nov 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T TantawichienV Sitprija
Jun 26, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·J M S Pearce
Jun 29, 2002·Journal of Travel Medicine·Pakamatz KhawplodHenry Wilde
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pakamatz KhawplodYongyuth Wangroonsarb
Apr 28, 2004·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·S N MadhusudanaM S Suja
Apr 18, 2007·Journal of Travel Medicine·Pakamatz KhawplodPranee Chomchey
Nov 7, 2007·Travel Medicine and Infectious Disease·Stephen Toovey
Jan 15, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Nguyen Cong VienJean Lang
Nov 14, 2008·Journal of Travel Medicine·Shungo YamamotoTadashi Matsumura
Dec 10, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Prapimporn ShantavasinkulTerapong Tantawichien
Mar 17, 2010·PLoS Neglected Tropical Diseases·Susan M Moore, Cathleen A Hanlon
Apr 3, 2010·PLoS Neglected Tropical Diseases·William H Wunner, Deborah J Briggs
May 14, 2010·Revista de saúde pública·Ricardo Siqueira CunhaRita Barradas Barata
Mar 17, 2011·PLoS Neglected Tropical Diseases·Katie HampsonDeborah Briggs
Nov 3, 2011·Expert Review of Vaccines·Xianfu WuCharles E Rupprecht
Aug 7, 2012·Clinical and Experimental Immunology·D J HicksN Johnson
Mar 3, 2017·Bulletin of the World Health Organization·Jocelyn A KesselsDeborah Briggs
Dec 1, 2017·Nature Reviews. Disease Primers·Anthony R FooksAshley C Banyard
Apr 10, 2018·Travel Medicine and Infectious Disease·Cornelis Adrianus De PijperCornelis Stijnis
May 23, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annefleur C LangedijkCornelis Stijnis
Jul 6, 2017·Tropical Medicine and Infectious Disease·Philippe BuchyPiyali Mukherjee
Nov 26, 2018·Vaccine·Arnaud TarantolaDeborah J Briggs
Dec 12, 2018·Vaccine·Katie HampsonCaroline Trotter

❮ Previous
Next ❯

Citations

Jul 3, 2021·Viruses·Deborah J Briggs, Susan M Moore
Jul 22, 2021·Tropical Medicine and Infectious Disease·Charles E Rupprecht

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03700242

Software Mentioned

MS Excel
PICOS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.